Innovative C.A.P. HD Duodenoscope recognized for improving clinical outcomes and the patient experience and for helping reduce the risk of infection.
Montvale, NJ (PRWEB) - PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, is pleased to announce that its innovative C.A.P. HD Duodenoscope (ED34-i10T) has been granted the Technology Breakthrough Award from Premier Inc., a leading healthcare improvement company.
The Premier Inc. Breakthrough Technology Award is based on a product accomplishing one or more of five criteria: improving patient or healthcare worker safety; improving clinical outcomes; improving non-clinical operational efficiencies; bridging a gap in care; and offering a dramatic process-of-care cost savings. With this award, the C.A.P. HD has been specifically recognized by Premier in three key areas:
In response to the award, David Woods, President and CEO, PENTAX Medical, Americas commented, “We are delighted to have received the Breakthrough Technology Award for the C.A.P. HD Duodenoscope by Premier, recognizing not only its clinical innovation to improved device design, but even more so the potential improvement to patient safety. In addition, Premier has also recognized PENTAX Medical’s overall organizational dedication to aligning itself with their hospital clients’ Triple Aim goals, which is a very meaningful achievement as well.”
The C.A.P. HD Duodenoscope is designed by PENTAX to improve the standards of treatment and safety for both routine and advanced ERCP via improved Clarity, Access, and Performance.
The C.A.P. HD is equipped with HD+ high-definition imaging for enhanced clinical visualization. Combined with i-SCAN and Optical Enhancement (OE), it is possible to clearly visualize the mucosa in detail and locate the papillae for cannulation.
The C.A.P. HD features the first detachable and single-use distal cap technology to be cleared and approved by the Food and Drug Administration (FDA). This design allows for improved access to critical components during cleaning and reprocessing.
The C.A.P. HD has introduced several additional advancements focused on improving overall performance during procedures, including a redesigned elevator for enhanced stability and control for precise cannulation of the papilla, an improved lightweight i10 Series Ergonomic Control Body designed for comfort and handling, as well as a large instrument channel to address ERCP therapeutic needs.
Premier, Inc. is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 165,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Effective September 1st, 2018, Premier members, at their discretion, are able to take advantage of special pricing and terms pre-negotiated by Premier for the C.A.P. HD Duodenoscope.
About PENTAX Medical
PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and enhance patients’ and providers’ experience by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading-edge R&D and manufacturing, PENTAX Medical provides endoscopy solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs. For more information, visit PENTAXMedical.com/US.